Abstract
The biogenetically interesting, structurally unique and biologically active metabolites of mangrove plants, with special growing environment such as high salinity, low oxygen and high humidity, have long been a research subject for chemists and pharmacologists during the last few decades. Based on the previous summaries on mangrove plants, this review elaborates the great recent progress of the chemistry and biological activities of diverse and complex metabolites in mangroves and some of their associated plants according to the structure types: terpenoids, alkaloids, polysulfides, phenolic molecules and miscellaneous, with the combination of their sources and bioactivities, covering the literatures from 2008 to 2014.
Keywords: Mangrove plant, terpenoid, limonoids, polysulfide, phenolic compounds, bioactivity.
Current Organic Chemistry
Title:Recent Progress on the Mangrove Plants: Chemistry and Bioactivity
Volume: 20 Issue: 18
Author(s): Fei Ye, Xu-Wen Li and Yue-Wei Guo
Affiliation:
Keywords: Mangrove plant, terpenoid, limonoids, polysulfide, phenolic compounds, bioactivity.
Abstract: The biogenetically interesting, structurally unique and biologically active metabolites of mangrove plants, with special growing environment such as high salinity, low oxygen and high humidity, have long been a research subject for chemists and pharmacologists during the last few decades. Based on the previous summaries on mangrove plants, this review elaborates the great recent progress of the chemistry and biological activities of diverse and complex metabolites in mangroves and some of their associated plants according to the structure types: terpenoids, alkaloids, polysulfides, phenolic molecules and miscellaneous, with the combination of their sources and bioactivities, covering the literatures from 2008 to 2014.
Export Options
About this article
Cite this article as:
Ye Fei, Li Xu-Wen and Guo Yue-Wei, Recent Progress on the Mangrove Plants: Chemistry and Bioactivity, Current Organic Chemistry 2016; 20 (18) . https://dx.doi.org/10.2174/1385272820666160421151209
DOI https://dx.doi.org/10.2174/1385272820666160421151209 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Hydroxamate and Anilide Derivatives as Potent Histone Deacetylase Inhibitors: Synthesis and Antiproliferative Evaluation
Current Medicinal Chemistry Oxidative Stress, Pro-Inflammatory Cytokines, and Antioxidants Regulate Expression Levels of MicroRNAs in Parkinson’s Disease
Current Aging Science Patent Selections
Recent Patents on Biomarkers Lipid Nanoparticles for the Delivery of Biopharmaceuticals
Current Pharmaceutical Biotechnology Autotaxin and Lysophosphatidic Acid Receptors as Novel Targets for the Radiosensitization of Tumor Vasculature in Non-Small Cell Lung Cancer
Current Angiogenesis (Discontinued) Calpain Inhibition: A Therapeutic Strategy Targeting Multiple Disease States
Current Pharmaceutical Design FDG-PET/CT Predicts Outcome in Oropharingeal Carcinoma Patients Undergoing Intensity Modulated Radiation Therapy with Dose Escalation to FDG-avid Tumour Volumes
Current Radiopharmaceuticals Role of Angiogenesis Inhibitors in Colorectal Cancer: Sensitive and Insensitive Tumors
Current Cancer Drug Targets The Yin and Yang of microRNA Assay Methods
MicroRNA Advanced Micro-Nano-Bio Systems for Future Targeted Therapies
Current Nanoscience Anti-miRNA-23a Oligonucleotide Suppresses Glioma Cells Growth by Targeting Apoptotic Protease Activating Factor-1
Current Pharmaceutical Design Active Subnetwork GA: A Two Stage Genetic Algorithm Approach to Active Subnetwork Search
Current Bioinformatics PPARγ and Its Ligands: Potential Antitumor Agents in the Digestive System
Current Stem Cell Research & Therapy Recent Advances in Multinuclear Complexes as Potential Anticancer and DNA Binding Agents
Anti-Cancer Agents in Medicinal Chemistry SALL4: Engine of Cell Stemness
Current Gene Therapy Headache: One of the Most Common and Troublesome Adverse Reactions to Drugs
Current Drug Safety Cisplatin Cytotoxicity: DNA and Plasma Membrane Targets
Current Medicinal Chemistry Coagulation and Cancer Therapy: The Potential of Natural Compounds
Current Genomics Nuclear Magnetic Resonance Spectroscopy of Lipids in Cancer
Current Organic Chemistry Overview of Prostate Biomarkers as Potential Targets for Immunotherapy
Current Cancer Therapy Reviews